381 related articles for article (PubMed ID: 34190033)
21. Probiotics and prevention of Clostridium difficile infection.
Goldstein EJC; Johnson SJ; Maziade PJ; Evans CT; Sniffen JC; Millette M; McFarland LV
Anaerobe; 2017 Jun; 45():114-119. PubMed ID: 27988389
[TBL] [Abstract][Full Text] [Related]
22. Bifidobacterium adolescentis and Lactobacillus rhamnosus alleviate non-alcoholic fatty liver disease induced by a high-fat, high-cholesterol diet through modulation of different gut microbiota-dependent pathways.
Wang G; Jiao T; Xu Y; Li D; Si Q; Hao J; Zhao J; Zhang H; Chen W
Food Funct; 2020 Jul; 11(7):6115-6127. PubMed ID: 32573567
[TBL] [Abstract][Full Text] [Related]
23. Co-Administration of Lactulose Crystals with Amoxicillin Followed by Prolonged Lactulose Treatment Promotes Recovery of the Human Gut Microbiome In Vitro.
Duysburgh C; Van den Abbeele P; Franckenstein D; Westphal M; Kuchinka-Koch A; Marzorati M
Antibiotics (Basel); 2022 Jul; 11(7):. PubMed ID: 35884216
[TBL] [Abstract][Full Text] [Related]
24. Effectiveness of Lactobacillus helveticus and Lactobacillus rhamnosus for the management of antibiotic-associated diarrhoea in healthy adults: a randomised, double-blind, placebo-controlled trial.
Evans M; Salewski RP; Christman MC; Girard SA; Tompkins TA
Br J Nutr; 2016 Jul; 116(1):94-103. PubMed ID: 27169634
[TBL] [Abstract][Full Text] [Related]
25. Pyrosequencing analysis reveals changes in intestinal microbiota of healthy adults who received a daily dose of immunomodulatory probiotic strains.
Plaza-Díaz J; Fernández-Caballero JÁ; Chueca N; García F; Gómez-Llorente C; Sáez-Lara MJ; Fontana L; Gil Á
Nutrients; 2015 May; 7(6):3999-4015. PubMed ID: 26016655
[TBL] [Abstract][Full Text] [Related]
26. Untargeted LC-QTOF-MS/MS based metabolomics approach for revealing bioactive components in probiotic fermented coffee brews.
Chan MZA; Lau H; Lim SY; Li SFY; Liu SQ
Food Res Int; 2021 Nov; 149():110656. PubMed ID: 34600658
[TBL] [Abstract][Full Text] [Related]
27. Probiotic Lactobacillus rhamnosus GG reduces mortality of septic mice by modulating gut microbiota composition and metabolic profiles.
Chen L; Li H; Chen Y; Yang Y
Nutrition; 2020 Oct; 78():110863. PubMed ID: 32593948
[TBL] [Abstract][Full Text] [Related]
28. Is Lactobacillus rhamnosus GG effective in preventing the onset of antibiotic-associated diarrhoea: a systematic review.
Hawrelak JA; Whitten DL; Myers SP
Digestion; 2005; 72(1):51-6. PubMed ID: 16113542
[TBL] [Abstract][Full Text] [Related]
29. Do Probiotics During In-Hospital Antibiotic Treatment Prevent Colonization of Gut Microbiota With Multi-Drug-Resistant Bacteria? A Randomized Placebo-Controlled Trial Comparing
Wieërs G; Verbelen V; Van Den Driessche M; Melnik E; Vanheule G; Marot JC; Cani PD
Front Public Health; 2020; 8():578089. PubMed ID: 33763399
[No Abstract] [Full Text] [Related]
30. Saccharomyces boulardii CNCM I-745 supports regeneration of the intestinal microbiota after diarrheic dysbiosis - a review.
Moré MI; Swidsinski A
Clin Exp Gastroenterol; 2015; 8():237-55. PubMed ID: 26316791
[TBL] [Abstract][Full Text] [Related]
31. Saccharomyces boulardii CNCM I-745 probiotic does not alter the pharmacokinetics of amoxicillin.
Selig DJ; DeLuca JP; Li Q; Lin H; Nguyen K; Scott SM; Sousa JC; Vuong CT; Xie LH; Livezey JR
Drug Metab Pers Ther; 2020 Mar; 35(1):. PubMed ID: 32134728
[TBL] [Abstract][Full Text] [Related]
32. Diversity of
Czerucka D; Rampal P
World J Gastroenterol; 2019 May; 25(18):2188-2203. PubMed ID: 31143070
[TBL] [Abstract][Full Text] [Related]
33. Anti-obesity effect of Lactobacillus rhamnosus LS-8 and Lactobacillus crustorum MN047 on high-fat and high-fructose diet mice base on inflammatory response alleviation and gut microbiota regulation.
Wang T; Yan H; Lu Y; Li X; Wang X; Shan Y; Yi Y; Liu B; Zhou Y; Lü X
Eur J Nutr; 2020 Sep; 59(6):2709-2728. PubMed ID: 31659451
[TBL] [Abstract][Full Text] [Related]
34. Microbiome Engineering Using Probiotic Yeast:
Kim J; Atkinson C; Miller MJ; Kim KH; Jin YS
Microbiol Spectr; 2023 Aug; 11(4):e0078023. PubMed ID: 37436157
[TBL] [Abstract][Full Text] [Related]
35. Effect of maifan stone on the growth of probiotics and regulation of gut microbiota.
Li Z; Zhou Q; Qu Q; Liao Y; Yang F; Sheng M; Feng L; Shi X
Lett Appl Microbiol; 2022 Dec; 75(6):1423-1432. PubMed ID: 35975465
[TBL] [Abstract][Full Text] [Related]
36.
Liu Y; Hoang TK; Taylor CM; Park ES; Freeborn J; Luo M; Roos S; Rhoads JM
Am J Physiol Gastrointest Liver Physiol; 2021 Jun; 320(6):G969-G981. PubMed ID: 33787352
[TBL] [Abstract][Full Text] [Related]
37.
Merenstein D; Fraser CM; Roberts RF; Liu T; Grant-Beurmann S; Tan TP; Smith KH; Cronin T; Martin OA; Sanders ME; Lucan SC; Kane MA
Nutrients; 2021 Aug; 13(8):. PubMed ID: 34444974
[TBL] [Abstract][Full Text] [Related]
38. Saccharomyces boulardii Administration Changes Gut Microbiota and Attenuates D-Galactosamine-Induced Liver Injury.
Yu L; Zhao XK; Cheng ML; Yang GZ; Wang B; Liu HJ; Hu YX; Zhu LL; Zhang S; Xiao ZW; Liu YM; Zhang BF; Mu M
Sci Rep; 2017 May; 7(1):1359. PubMed ID: 28465509
[TBL] [Abstract][Full Text] [Related]
39. Restitution of gut microbiota in Ugandan children administered with probiotics (
Castro-Mejía JL; O'Ferrall S; Krych Ł; O'Mahony E; Namusoke H; Lanyero B; Kot W; Nabukeera-Barungi N; Michaelsen KF; Mølgaard C; Friis H; Grenov B; Nielsen DS
Gut Microbes; 2020 Jul; 11(4):855-867. PubMed ID: 31959047
[TBL] [Abstract][Full Text] [Related]
40. Saccharomyces boulardii CNCM I-745: A Non-bacterial Microorganism Used as Probiotic Agent in Supporting Treatment of Selected Diseases.
Kaźmierczak-Siedlecka K; Ruszkowski J; Fic M; Folwarski M; Makarewicz W
Curr Microbiol; 2020 Sep; 77(9):1987-1996. PubMed ID: 32472262
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
